The in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a more effective method for the sustained delivery of medicines for retinal and ...

Regular Yoga Practice Is Associated With Mindful Eating

... at Fred Hutchinson Cancer Research Center. the study was prompted by initial findings reported ... weight loss in those who are overweight. At the time, the researchers suspected ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... Pa., Aug. 7 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), announced today the company has submitted ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... survival (PFS) compared with FOLFOX alone in the first-line treatment of patients with KRAS ... of Research and Development at Amgen. "These are the first prospective Phase 3 data to demonstrate the utility of KRAS mutational analysis as a ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... ISIS ) today announced its financial results for the quarter ended June 30, 2009. During 2009 Isis ... reported $669,000 of pro forma net income for the quarter ended June 30, 2009, a significant improvement over the same period in 2008. Isis also reported a pro ...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- the Juvenile Diabetes Research Foundation said today ... a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... treatment options to its patients through the addition of High Dose Rate (HDR) brachytherapy. ... patient's cancerous tumor and is rapidly becoming the treatment of choice for certain types of cancer. ... brachytherapy, radiation is delivered directly to the cancer target ...

SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite

... (CRO) founded in India, today announced the successful completion of the implementation phase of the Oracle Life Science Application Suite (OLSAS) by ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... that in women with osteoporosis, BA058 -- the company's novel PTHrP (parathyroid ... increased bone mineral density (BMD) at the lumbar spine and femoral neck (a common fracture site located in the hip joint) after six months of ....

NewCardio Announces Master Services Agreement With Dedicated Phase I

... existing infrastructure, will be able to deliver the full range of TQT/QTc studies, becoming a turnkey ... we can deliver TQT/QTc studies for upload to the FDA digital ECG warehouse with greater accuracy and lower intrinsic variability than the legacy manual or semi-automated methodologies ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... it has filed a New Drug Submission (NDS) with the Therapeutic Products Directorate of Health Canada for its novel formulation of the antidepressant trazodone. "We are pleased to ... Executive Officer, Labopharm Inc. "We believe the $800 million-plus Canadian market for ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... particle (VLP) vaccine candidate against the H1N1 pandemic influenza virus under current ... was accomplished in only 11 weeks after receiving the gene sequence for the H1N1 strain ...

2,500 Cases Completed With the Magnetic Irrigated Catheter

... have performed more than 2,500 procedures with the magnetic irrigated catheter since its commercial release. the clinical performance of the catheter in these cases has been ....

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... NKTR ) today reported its financial results for the second quarter ended June 30, 2009. Net loss for the quarter ended June 30, 2009 was $32.1 million or ... net loss of $33.4 million or $0.36 per share in the second quarter of 2008. Nektar made ...

DNA Helps Reunite Children With Their Families

... Texas, Aug. 4 /PRNewswire-USNewswire/ -- Of the 600,000-800,000 people trafficked across ... estimated that by 2010, human trafficking will be the No. 1 crime worldwide. Arthur Eisenberg, Ph.D., professor and chairman of the department of forensic and investigative Genetics ...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

... laboratory research and development, supports the U.S. Food and Drug Administration's (FDA) decision to put KRAS on the label of two targeted drugs, Vectibix (panitumumab) and Erbitux (cetuximab). On July 17, 2009, the FDA noted that, "retrospective analyses of ...

Study Shows Brain Fitness can Save Medicare Billions

... Aug. 4 /PRNewswire/ -- Just ten hours of the right brain fitness exercises can have a ... costs by hundreds of dollars per year. As the number of Medicare enrollees grows from 44 million to 61 million over the next ten years, this represents more than $100 ...

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research

... EINDHOVEN, the Netherlands, August 4 /PRNewswire/ -- With ... of a research project into prostate cancer, the Dutch CTMM (Center for Translational Molecular Medicine) today announced the successful completion of 265 million euro funding ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... group of companies with a focus on the development of prescription drugs that target ... cancer, and cardiovascular disease, announce the signature of an exclusive license agreement for the development and commercialisation of Debio 0930, ...

Scientists Discover Origin of Malaria

... scientists reported that they have discovered the origin of malaria, one of the deadliest diseases of humanity. Chimpanzees, native to equatorial Africa, have been identified as the original source ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... administered as an intravenous (IV) infusion in the treatment of bone metastases in 1,776 advanced ... cancer) or multiple myeloma. For the primary endpoint, patients treated with denosumab ... (p<0.0007). Although numerically greater, the delay ...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

... Inc. (Nasdaq: TELK ) today announced that the positive results from a Phase 1 multicenter, dose ... formulation of TELINTRA were published earlier in the Journal of Hematology and Oncology, 13 May 2009; Vol. 2, No.20, pp. 20-32. the findings reported from these studies ...

Project Zero Delay Accelerates Drug's Path to Clinical Trial

... U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer ... takes three to six months. Investigators from the University of Texas M. D. Anderson Cancer Center ... company AstraZeneca have reported their work in the Journal of Clinical Oncology published online ...

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

... PHOENIX, Aug. 3 /PRNewswire-USNewswire/ -- the Phoenix-based Kronos Longevity Research Institute ... hormone therapies and their effects on reducing the risks of cardiovascular disease in older adults. ... disease caused by atherosclerosis, or the build-up of plaques ...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

... CHICAGO, Aug. 3 /PRNewswire-USNewswire/ -- the Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer issues and topics that were the focus of its Forum ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... TITUSVILLE, N.J., Aug. 3 /PRNewswire/ -- the U.S. Food and Drug Administration approved ... extended-release injectable suspension for the acute and maintenance treatment of schizophrenia in adults on Friday, July 31, 2009. It is the first once-monthly, long-acting, injectable ...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

... a new clinical study of ProLindac in France. the study will examine dose levels and regimens of ... design of combinations studies, and extend the safety database. Two ovarian cancer patients have been enrolled in the study to date, and it is anticipated 6 to 12 ...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

... cameras and its new medical devices camera; the smallest of its kind in the world, designated to be incorporated into ... the camera is expected to commence in mid-2010. the camera sensor will be manufactured in Tower's ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

... -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today reported positive results from the first of three Phase III studies of velaglucerase ... for the treatment of Type 1 Gaucher disease. the Company also announced ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... released by Dartmouth-Hitchcock Medical Center at the International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer. the study demonstrated that in patients with advanced ...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

... July 29th, every purchase at select Gap stores in the New York tri-state area will include a special ... code enabling shoppers to obtain one ticket in the reserved RED(ZONE) section for John Legend's MSG ... will automatically receive a second ticket to the show free of charge. Additionally, a select ...

Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus

... alert students about disease prevention, monitor the spread of infection, and track vaccination compliance. FairChoice Health is the first and only end-to-end service for vaccination ... designed for colleges and universities. the enhancement of FairChoice Health adds tracking ...

GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip

... Alliance executive director Dr. Paul Zeitz issued the following statement today on the eve of Secretary of State Hillary Clinton's ... and violence, including gender-based violence, on the African continent. Violence against women (VAW) ...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

... from its phase I clinical trial of PSI-7851 for the treatment of hepatitis C (HCV). PSI-7851 is a ... 1 multiple ascending dose study with PSI-7851. the trial was conducted at two US centers, as a ... chronically infected with HCV genotype 1. the primary objective was to ...

British Woman Celebrates a Year of Living Cancer-Free

... -- and made history to boot. Ms. Scott, 54, was the first person in the world to receive an injection of tumor-activated ... a treatment for leukemia. Her doctors at the Royal Free Hospital in London recommended this ...

Covance Receives Highest Level of Phase I Accreditation

... standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory ... that research facilities and studies meet the industry's highest safety standards. ...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... -- When minimally invasive endovascular (through the vessel) therapy made its debut two decades ago, stroke care underwent a major shift as the "window of treatment" for patients suffering a ... to eight hours within symptom onset, rather than the standard three-hour window required ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) ... sublingual tablets as effective and safe for the acute treatment of manic or mixed episodes ... in adults. If approved by FDA, SAPHRIS would be the first psychotropic drug to be approved initially ...

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

... announced today that scientists reporting in the July 31 issue of SCIENCE have discovered a key ... and advanced in vivo imaging technologies. the newly reported biologic pathway relates to monocyte deployment from the spleen to inflammatory sites, including ...

New Powder Speeds Healing of Difficult Foot Wounds

... Study Discussed at the American Podiatric Medical Association's 97th ... such as open wounds and ulcers, can be one of the most difficult ailments for a podiatrist to ... much like a layer of skin, is proving to speed the healing time and ...